ArticleJournal of inflammation research2026
OLR1 as a Key Inflammatory Regulator Associated with Poor Response to Neoadjuvant Immunochemotherapy in Resectable Lung Cancer.
Xinxin Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.